Hepaticojejunostomy for hepatolithiasis: A critical appraisal

Table 1 Patients’ demographic and clinical data

Groups	n	PS1n (%)	Age (yr)	Hospital stay (d)	Operative time (min)	History2 (yr)	Bleeding2 (mL)
HJ group	123	90 (73.17)
+hepatectomy (A1)	76	55 (72.37)a	45.4 ± 13.8	32.1 ± 12.0	282.9 ± 99.3a	8.5a	500.0a
left lateral segmentectomy	52					(0.1-40)	(150-27 000)
left hepatectomy	15
right hepatectomy	3
segmentectomy	6
+CBD exploration (A2)	47	35 (74.47)c	51.8 ± 13.5	27.0 ± 8.5	226.1 ± 80.4	8.0c	300.0
						(0.1-35)	(100-3000)
T tube drainage group	191	102 (53.40)
+hepatectomy (B1)	85	46 (54.12)	46.6 ± 12.6	29.2 ± 10.6	189.4 ± 54.1c	3.5	300.0c
left lateral segmentectomy	57					(0.1-40)	(100-5000)
left hepatectomy	13
right hepatectomy	4
segmentectomy	11
+ CBD exploration (B2)	106	56 (52.83)	49.8 ± 15.7	28.3 ± 16.6	166.4 ± 97.7	3.0	150.0
						(0.1-40)	(30-18 000)

^aP < 0.05 vs group B1,

^cP < 0.05 vs group B2.

¹ps: previous bile surgery,

²expressed as median (range). Age, hospital stay and operative time were expressed as mean ± SD. CBD: common bile duct; HJ: hepaticojejunostomy.

Table 2 Sites and rates of residual stone

Groups	n	Site of stone residual					Rate
		Leftliver	Rightliver	CBD	Leftliver	Rightliver	Total (%)
HJ group	123	8	14	1	2	25	20.3a
+hepatectomy (A1)	76	3	10	1	0	14	18.4
+CBD exploration (A2)	47	5	4	0	2	11	23.4
T tube drainage group	191	17	22	3	12	54	28.3
+ hepatectomy (B1)	85	5	10	1	2	18	21.2
+ CBD exploration (B2)	106	12	12	2	10	36	34.0

HJ, hepaticojejunostomy; CBD, common bile duct.

^aP > 0.05 vs T tube drainage group.

Table 3 Postoperative complications

Complications	Group A1	Group A2	Group B1	Group B2
	(n = 76)	(n = 47)	(n = 85)	(n = 106)
Wound infection	6	3	5	7
Subphrenic collection/infection	7	0	3	0
Pleural infusion	3	0	2	0
Bile leakage	2	0	3	1
Biliary hemorrhage	1	0	0	2
Liver abscess	1	0	0	0
Liver failure	1	2	0	6
Pulmonary infection	0	1	1	1
Septicemia	1	0	0	0
Total	22	6	14	17
%	28.95a	12.77	16.47	16.04

^aP < 0.05 vs group A2.

Table 4 Follow-up and postoperative cholangitis

Groups	n	Follow-uppatients(n, %)	Postoperativecholangitis(n, %)	Causes of cholangitis
				ST	SR	SRE	RC
HJ group	123	96 (78.0)	23 (24.0)	3	16	(3)4	1
+ hepatectomy (A1)	76	59 (77.6)	13 (22.0)	1	9	3	0
+ CBD exploration (A2)	47	37 (78.7)	10 (27.0)	2	7	(2)3	1
T tube drainage group	191	145 (76.0)	35 (24.1)	0	1	34	0
+ hepatectomy (B1)	85	61 (71.8)	5 (8.2)1	0	0	5	0
+ CBD exploration (B2)	106	84 (79.2)	30 (35.7)2	0	1	29	0

¹P = 0.034 vs group A1.

²P = 0.349 vs group A2. ^{3, 4}these two (or three patients) patients who had stone recurrence also had stricture of anastomosis. HJ: hepaticojejunostomy, ST: stricture of anastomosis or intrahepatic bile duct, SR: stone residual; SRE: stone recurrence; RC: reflux cholangitis.